G1 Therapeutics, Inc. — Form D

G1 Therapeutics, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-12. The offering totals $33.0M, of which $16.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Michael A GutchDirectorResearch Triangle Park, NC
Norman A SharplessDirectorResearch Triangle Park, NC
Clay A ThorpDirectorResearch Triangle Park, NC
Carol A WebbDirectorResearch Triangle Park, NC
Gregory A MossinghoffExecutive OfficerResearch Triangle Park, NC
Clay ThorpDirectorDurham, NC
Christy ShafferDirectorDurham, NC
Norman SharplessDirectorPalo Alto, CA
Christy A ShafferDirectorDurham, NC
Peter A KolchinskyDirectorSeattle, WA
Carol WebbDirectorCranford, NJ
SETH A RUDNICKDirectorMORRISVILLE, NC
Timothy N SullivanDirectorRESEARCH TRIANGLE PARK, NC
Mark A VellecaDirectorRESEARCH TRIANGLE PARK, NC
Mark A VellecaExecutive OfficerRESEARCH TRIANGLE PARK, NC
Glenn A MuirDirectorRESEARCH TRIANGLE PARK, NC
Gregory N MossinghoffExecutive OfficerRESEARCH TRIANGLE PARK, NC
Ron A LauferDirectorRESEARCH TRIANGLE PARK, NC
Frederic N EshelmanDirectorRESEARCH TRIANGLE PARK, NC
Ron K LauferDirectorResearch Triangle Park, NC
Michael K GutchDirectorResearch Triangle Park, NC
Thomas K LaundonExecutive OfficerResearch Triangle Park, NC
Jay K StrumExecutive OfficerResearch Triangle Park, NC
Seth K RudnickDirectorResearch Triangle Park, NC
Jay StrumDirectorChapel Hill, NC

Other filings by this issuer (7)

FiledFormOfferingSold
2016-07-01D/A$50.0M$50.0M
2016-05-11D$50.0M$47.0M
2014-06-23D/A$12.6M$12.6M
2013-10-17D$12.6M$6.3M
2013-08-23D/A$1.3M$1.2M
2013-04-18D$1.0M$458K
2012-10-12D$763K$763K

More